Krystal Biotech Inc
NASDAQ:KRYS

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
NASDAQ:KRYS
Watchlist
Price: 177.39 USD -3.71% Market Closed
Market Cap: 5.1B USD
Have any thoughts about
Krystal Biotech Inc?
Write Note

Krystal Biotech Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Krystal Biotech Inc
Total Current Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Krystal Biotech Inc
NASDAQ:KRYS
Total Current Assets
$713.2m
CAGR 3-Years
27%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Current Assets
$27.8B
CAGR 3-Years
-1%
CAGR 5-Years
7%
CAGR 10-Years
5%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Assets
$13.1B
CAGR 3-Years
-2%
CAGR 5-Years
-14%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Total Current Assets
$26.8B
CAGR 3-Years
3%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Assets
$9.8B
CAGR 3-Years
3%
CAGR 5-Years
15%
CAGR 10-Years
20%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Assets
$19.3B
CAGR 3-Years
12%
CAGR 5-Years
22%
CAGR 10-Years
24%

See Also

What is Krystal Biotech Inc's Total Current Assets?
Total Current Assets
713.2m USD

Based on the financial report for Sep 30, 2024, Krystal Biotech Inc's Total Current Assets amounts to 713.2m USD.

What is Krystal Biotech Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
28%

Over the last year, the Total Current Assets growth was 23%. The average annual Total Current Assets growth rates for Krystal Biotech Inc have been 27% over the past three years , 28% over the past five years .

Back to Top